Form D · Biotechnology

TYBR Health, Inc.

Houston, TX · CIK 0001835188

Offering snapshot reported Jul 22, 2026 · SEC filing

Reported sold
$14.4M
Offering amount: $30M
Investors reported
12
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 9, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 22, 2026Initial$14,354,342No comparison12SEC filing
Nov 26, 2025Amendment$7,142,974$6,058,295vs Jan 31, 202550SEC filing
Jan 31, 2025Initial$1,084,679No comparison8SEC filing
Dec 9, 2020Initial$709,999No comparison8SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-591721

Source: Form D, filed Jul 22, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Greg Banker Director
Cooper Collins Director
Tom Dugan Director
Toby Hamilton Director
Timothy J. Keane Director, Executive
Timothy J. Keane Jr. Director, Executive
Timothy J. Keane, Jr. Director, Executive, Promoter
Stephen Ramon Executive
Alex Smith Director, Executive
Aaron Smith Director
Jeffrey Tyber Director
Liz Zambory Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2450 Holcombe Blvd. Suite X
Houston, TX, 77021
Phone: 832-384-5423